- Home
- IQST vs COEP Comparison
IQST vs COEP Comparison
Compare IQST & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQST
- COEP
- Stock Information
- Founded
- IQST 2011
- COEP 2017
- Country
- IQST United States
- COEP United States
- Employees
- IQST N/A
- COEP N/A
- Industry
- IQST
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IQST
- COEP Health Care
- Exchange
- IQST NYSE
- COEP Nasdaq
- Market Cap
- IQST 32.6M
- COEP 27.4M
- IPO Year
- IQST N/A
- COEP N/A
- Fundamental
- Price
- IQST $9.58
- COEP $9.47
- Analyst Decision
- IQST Strong Buy
- COEP
- Analyst Count
- IQST 1
- COEP 0
- Target Price
- IQST $18.00
- COEP N/A
- AVG Volume (30 Days)
- IQST 117.1K
- COEP 37.4K
- Earning Date
- IQST 08-11-2025
- COEP 08-15-2025
- Dividend Yield
- IQST N/A
- COEP N/A
- EPS Growth
- IQST N/A
- COEP N/A
- EPS
- IQST N/A
- COEP N/A
- Revenue
- IQST $289,438,380.00
- COEP $62,874.00
- Revenue This Year
- IQST N/A
- COEP N/A
- Revenue Next Year
- IQST N/A
- COEP N/A
- P/E Ratio
- IQST N/A
- COEP N/A
- Revenue Growth
- IQST 69.01
- COEP N/A
- 52 Week Low
- IQST $7.47
- COEP $2.31
- 52 Week High
- IQST $19.00
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- IQST N/A
- COEP 62.24
- Support Level
- IQST N/A
- COEP $7.25
- Resistance Level
- IQST N/A
- COEP $9.90
- Average True Range (ATR)
- IQST 0.00
- COEP 0.63
- MACD
- IQST 0.00
- COEP 0.26
- Stochastic Oscillator
- IQST 0.00
- COEP 85.62
About IQST IQSTEL INC
iQSTEL Inc is a technology company offering a wide array of services to the telecom and Internet industry. The business divisions of the company are Telecommunication including VoIP, SMS, International Fiber-Optic, Proprietary Internet of Things (IoT), and a Proprietary Mobile Portability Blockchain Platform; the Fintech division includes remittances services, top-up services, Master Card Debit Card, a USA Bank Account, and a Mobile App; Electric Vehicles division offers Electric Motorcycles and plans to launch a Mid Speed Car; and the Metaverse division includes Metaverse platform to access products, services, content, entertainment, information, customer support, and more in a virtual 3D interface. Geographically, it derives a majority of its revenue from the USA.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.